English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    L.I. Vakulenko, A.Ye. Abaturov, О.V. Kunak

    LEFT VENTRICULAR GEOMETRY IN CHILDREN WITH CHRONIC PYELONEPHRITIS AT EARLY STAGES OF THE CHRONIC KIDNEY DISEASE


    About the author: L.I. Vakulenko, A.Ye. Abaturov, О.V. Kunak
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The purpose of the study was to determine the features of the left ventricular geometry in children with chronic pyelonephritis at the initial stages of the CKD. The tendency towards a gradual increase of the left ventricular cavity with the chronic kidney disease progression has been established, so that in patients of group 3 the end-diastolic index and the end-systolic index were significantly different from the statutory indices. A statistically significant increase in the of myocardial mass index was recorded in patients of the 1 st (p = 0.02), 2nd (p = 0.016) and 3rd (p <0.001) groups. In general, left ventricular hypertrophy was determined in 15.4% of patients in the 1st group, 36.7% - in the 2nd group, 47% - in the 3 rd group. In children with chronic pyelonephritis from the early stage of chronic kidney disease, processes of left ventricular remodeling occur, which are characterized by the formation of predominantly eccentric hypertrophy.
    Tags children, chronic pyelonephritis, chronic kidney disease, hypertrophy of the left ventricle
    Bibliography
    • Kondratyev VO, Vakulenko LI, Porokhnya NG, Tkachenko NP, Andreychenko II. Sertceva diyalnist u zdorovykh ditey za danymy ekhokardiohrafiyi. Medychni perspektyvy. 2011; 16(4), 112-118. [in Ukrainian].
    • Badve SV, Palmer SC, Strippoli GFM, Roberts MA, Teixeira-Pinto A, Boudville N. et al. The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: a systematic review and meta-analysis. Am J Kidney Dis. 2016; 68: 554–563.
    • Cai QZ, Lu XZ, Lu Y, Wang AY. Longitudinal changes of cardiac structure and function in CKD (CASCADE study). J Am Soc Nephrol. 2014; 25: 1599–1608.
    • Chinali M, Matteucci MC, Franceschin A, Doyon A, Pongiglione G, Rinelli G, Schaefer F. Advanced Parameters of Cardiac Mechanics in Children with CKD: The 4C Study. CJASN. 2015; 10(8):1357-1363.
    • Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, Zachariah JP, Urbina EM. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014; 63(5):1116-35.
    • Mahmoodi BK., Matsushita K, Woodward, Blankestijn PJ, Cirillo M, Ohkubo T. et al. Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.  Lancet. 2012; 380(9854):1649-61.
    • Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T. et al. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography. J Nephrol. 2012; 25(5):794.
    • Matteucci MC, Chinali M, Rinelli G, Wuhl E, Zurowska A, Charbit M. et al. Change in Cardiac Geometry and Function in CKD Children During Strict BP Control: A Randomized Study. Clin J Am Soc Nephrol. 2013; 8(2):203-210.
    • Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA. 2013; 309: 1921–1929.
    • Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B. CKiD Study Group: Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010; 21: 137–144.
    • Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L. et al. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension. Clin J Am Soc Nephrol. 2016; 5; 11(2):271-9.
    • Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG. Chronic Renal Insufficiency Cohort (CRIC) Study Group: Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012; 23: 1725–1734.
    • Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A. et al. Cardiovascular Phenotypes in Children with CKD: The 4C Study. CJASN. 2017; 12 (1) 19-28.
    • Soliman EZ, Prineas RJ. Antihypertensive Therapies and Left Ventricular Hypertrophy. Curr Hypertens Rep. 2017; 19(10):79.
    • Weaver DJJr, Somers MJG, Martz K, Mitsnefes MM. Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry. Pediatr Nephrol. 2017; 32:2319–2330.
    Publication of the article «World of Medicine and Biology» №2(68), 2019 year, 025-029 pages, index UDK 616.613-002-036.1-036.4:616.12-073.432.19]-053.2
    DOI 10.26724/2079-8334-2019-2-68-25-29